IL10 and COVID-19: PGE2 may participate in the conversion of pro-inflammatory interleukins (e.g., IL-1β and IL-6) to anti-inflammatory interleukins synthesized by M2 macrophages (e.g., IL-10) [51], which may explain the significant increase in IL-10 in patients who survived COVID-19.